Carbonyl reductase 1 Antibodies

Santa Cruz Biotechnology provides a broad selection of Carbonyl Reductase 1 monoclonal antibodies for research applications. Carbonyl reductase 1 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Carbonyl reductase 1 is a key enzyme involved in the reduction of carbonyl compounds to their corresponding alcohols, playing a crucial role in drug metabolism and the detoxification of harmful substances. Its function is vital in various physiological processes, including the regulation of cellular redox states and the modulation of oxidative stress. Understanding the activity and regulation of Carbonyl Reductase 1 is essential for elucidating its implications in metabolic disorders and potential therapeutic targets. Research focusing on Carbonyl Reductase 1 has revealed its significance in cellular protection against oxidative damage. The enzyme's involvement in drug metabolism makes it particularly relevant for pharmaceutical research and development. Investigating Carbonyl Reductase 1 activity can provide valuable insights into metabolic pathways and potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of Carbonyl Reductase 1 and its impact on human health.